Search

This survey study uses data from the Centers for Medicare and Medicaid Services, the American Hospital Association, and US News & World Report to compare services available in hospitals with and without 5-star patient experience summary ratings.

Importance Inpatient care providers often order laboratory tests without any appreciation for the costs of the tests. Objective To determine whether we could decrease the number of laboratory tests ordered by presenting providers with test fees at the time of order entry in a tertiary care hospital, without adding extra steps to the ordering process. Design Controlled clinical trial. Setting Tertiary care hospital. Participants All providers, including physicians and nonphysicians, who ordered laboratory tests through the computerized provider order entry system at The Johns Hopkins Hospital. Intervention We randomly assigned 61 diagnostic laboratory tests to an “active” arm (fee displayed) or to a control arm (fee not displayed). During a 6-month baseline period (November 10, 2008, through May 9, 2009), we did not display any fee data. During a 6-month intervention period 1 year later (November 10, 2009, through May 9, 2010), we displayed fees, based on the Medicare allowable fee, for active tests only. Main Outcome Measures We examined changes in the total number of orders placed, the frequency of ordered tests (per patient-day), and total charges associated with the orders according to the time period (baseline vs intervention period) and by study group (active test vs control). Results For the active arm tests, rates of test ordering were reduced from 3.72 tests per patient-day in the baseline period to 3.40 tests per patient-day in the intervention period (8.59% decrease; 95% CI, −8.99% to −8.19%). For control arm tests, ordering increased from 1.15 to 1.22 tests per patient-day from the baseline period to the intervention period (5.64% increase; 95% CI, 4.90% to 6.39%) (P Conclusions and Relevance Presenting fee data to providers at the time of order entry resulted in a modest decrease in test ordering. Adoption of this intervention may reduce the number of inappropriately ordered diagnostic tests.

Patients receiving anticoagulation for venous thromboembolism (VTE) have varying risks of recurrence on cessation of the therapy. Time from the most recent thrombotic event is perhaps the most important determinant of short-term VTE recurrence because patients who stop anticoagulation therapybefore the stabilizationof an active thrombus are particularly prone to propagation and embolization. If use of anticoagulation is stopped during the first 4 weeks of treatment, the risk of recurrent VTE is 0.3% to 1.3% per day, dropping to 0.03% to 0.2% per day over the next 4 to 12 weeks.1 After 3months, many patients can safely discontinue anticoagulation therapy, particularly if the thrombotic event occurred in the setting of a reversible precipitant. The importanceofdetermining the time frameof themost recent thrombotic episode is reflected in the currentAmerican College of Chest Physicians (ACCP) guidelines,2 which suggest stratifying patients who are receiving anticoagulation therapy for a history of VTE are at high risk for recurrence during anticoagulant cessation if the thrombosis occurredwithin the previous 3 months, intermediate risk if the thrombosis occurred within the past 3 to 12 months, and low risk if the event occurredmorethan12monthsearlier.Hypercoagulabilitycanalso tippatients intohigher-risk categories: theACCPguidelines include as high-risk thrombophilias homozygous prothrombotic mutations; protein C, S, or antithrombin deficiency; antiphospholipid antibodies; or multiple thrombophilic traits. Intermediate-riskthrombophilias includecancer, recurrentVTE, andsingleprothromboticmutations.Thisparadigmismoreconservative thanother suggested schemas that donot categorize all patientswithVTE in thepreceding3monthsashigh riskand give lowerpriority to laboratory-based thrombophilias that are not associated with recurrent VTE.1 In recent years, the literature3,4 has highlighted the bleeding risk conferred by use of full-dose anticoagulants following surgicalprocedures,particularlywhenthemedication isstarted in the first 2 to 3 days after surgery. Yet, for patients with prior VTE, the postoperative setting is a particularly high-risk time for recurrence since surgery itself is a potent VTE precipitant. Giventhisclinical landscape, thearticlebyClarkandcolleagues5 in this issue of JAMA Internal Medicine is a welcome addition totheliterature.Leveragingalargeadministrativedatabasefrom an integratedhealth care system, these authors identified 1812 procedures in 1178 patients receiving warfarin for VTE who stoppeditsuse intheperiprocedural setting.Bridgetherapywas identified by the purchase of parenteral anticoagulants by patientsandbyreviewofperiproceduralplansdocumented inanticoagulationclinic records.Bleedingandthromboticeventsoccurring within 30 days of the procedure were adjudicated via manual review of the medical records. Patient risk was stratified in accordance with current ACCP guidelines.2 However, since bridgingwas not standardized, approximately one-third of patients in the lowand intermediate-risk strata received bridgetherapy,andfewerthantwo-thirdsofpatients inthehighrisk stratum received bridge therapy. Consistentwithprior studies,4 2.7%of thepatientswhoreceived bridge therapy developed clinically relevant bleeding compared with only 0.2% of those who did not receive bridge anticoagulationtherapy.More important,only3patients (0.2%) who did not receive bridge therapy developed recurrent VTE. None of the 21 high-risk patients and only 1 of the 215 intermediate-riskpatientswhodidnot receivedbridge therapyhad recurrentVTE.Toputthesefindings instarkterms,bridgetherapy, despite being administered to only one-third of patients overall, ledtoapproximately14incrementalclinicallyrelevantbleeding events,whereas therewereonly 3 thrombotic events in the remaining two-thirds of the cohort who did not receive bridge therapy, with no signal that the current ACCP risk-stratificationschemasuccessfully identifiedpatientsathighenoughrisk for thrombosis to justifybridgetherapy.Althoughthisstudywas not powered to assess mortality (with no deaths in the entire cohort), we know from other studies that approximately 10% ofVTEpatientswhohavemajor bleedingdie,6,7 comparable to the case fatality rate from recurrent VTE.7,8 In contrast to patientswho experience cardioembolism, survivors of recurrent deep vein thrombosis or pulmonary embolism rarely have serious permanent sequelae. The present study is not without its limitations, particularly the lackof discriminationbetween full-dose andprophylactic-dose parenteral anticoagulants used as bridge therapy and the absence of information on the timing of anticoagulation therapy. Nevertheless, it is likely that the imbalance between bleeding and thrombotic events between subgroups would have been even more dramatic had all patients in the bridge therapygroup received full-doseparenteral anticoagulants in the immediatepostoperative setting.As such,we support theauthors’ contention that themajority—indeed thevast majority—of patients receiving anticoagulants for a history of VTE shouldnot be given therapeutic-dosebridge therapy, and that revision of the ACCP risk-stratification recommendations is warranted. There are undoubtedly some patients at such high risk for recurrent VTE that bridge therapy is a necessary evil, such as those with acute VTE in the preceding month and thosewith a prior pattern of brisk VTE recurrence during short-term interruption of anticoagulation therapy. Related article page 1163 Risks DuringWarfarin Interruption for Invasive Procedures Original Investigation Research

Importance Poor health care provider communication across health care settings may lead to adverse outcomes. Objective To determine the frequency with which inpatient providers report communicating directly with outpatient providers and whether direct communication was associated with 30-day readmissions. Design We conducted a single-center prospective study of self-reported communication patterns by discharging health care providers on inpatient medical services from September 2010 to December 2011 at The Johns Hopkins Hospital. Setting A 1000-bed urban, academic center. Participants There were 13 954 hospitalizations in this time period. Of those, 9719 were for initial visits. After additional exclusions, including patients whose outpatient health care provider was the inpatient attending physician, those who had planned or routine admissions, those without outpatient health care providers, those who died in the hospital, and those discharged to other healthcare facilities, we were left with 6635 hospitalizations for analysis. Interventions Self-reported communication was captured from a mandatory electronic discharge worksheet field. Thirty-day readmissions, length of stay (LOS), and demographics were obtained from administrative databases. Data Extraction We used multivariable logistic regression models to examine, first, the association between direct communication and patient age, sex, LOS, race, payer, expected 30-day readmission rate based on diagnosis and illness severity, and physician type and, second, the association between 30-day readmission and direct communication, adjusting for patient and physician-level factors. Results Of 6635 included hospitalizations, successful direct communication occurred in 2438 (36.7%). The most frequently reported reason for lack of direct communication was the health care provider's perception that the discharge summary was adequate. Predictors of direct communication, adjusting for all other variables, included patients cared for by hospitalists without house staff (odds ratio [OR], 1.81 [95% CI, 1.59-2.08]), high expected 30-day readmission rate (OR, 1.18 [95% CI, 1.10-1.28] per 10%), and insurance by Medicare (OR, 1.35 [95% CI, 1.16-1.56]) and private insurance companies (OR, 1.35 [95% CI, 1.18-1.56]) compared with Medicaid. Direct communication with the outpatient health care provider was not associated with readmissions (OR, 1.08 [95% CI, 0.92-1.26]) in adjusted analysis. Conclusions and Relevance Self-reported direct communication between inpatient and outpatient providers occurred at a low rate but was not associated with readmissions. This suggests that enhancing interprovider communication at hospital discharge may not, in isolation, prevent readmissions.